23andMe, the genetic testing company that has amassed a vast trove of personal genetic data, is facing a crisis. The company, once valued at billions, has seen its stock plummet by over 95%. Nearly all the board (other than Anne Wojcicki), has resigned. This collapse has left the company with one valuable asset: the genetic data of its customers. The plan is to sell this data to the highest bidder, a move that will have far-reaching consequences for those who trusted the company with their most intimate biological information... the details of which can be weaponized against individuals.
I discuss some of those impacts here....<<<Read More>>>...